HomeRGLS • NASDAQ
add
Regulus Therapeutics Inc
$1.78
Makalipas ang Oras ng Trabaho:(7.30%)-0.13
$1.65
Sarado: Abr 11, 5:49:14 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.72
Sakop ng araw
$1.63 - $1.84
Sakop ng taon
$0.83 - $2.90
Market cap
117.91M USD
Average na Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | -19.51M | -59.75% |
Net na kita | -12.79M | -58.68% |
Net profit margin | — | — |
Kita sa bawat share | -0.20 | 50.00% |
EBITDA | -13.66M | -66.09% |
Aktuwal na % ng binabayarang buwis | 0.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 75.78M | 218.83% |
Kabuuang asset | 84.18M | 173.76% |
Kabuuang sagutin | 7.77M | -18.72% |
Kabuuang equity | 76.41M | — |
Natitirang share | 66.24M | — |
Presyo para makapag-book | 1.47 | — |
Return on assets | -38.62% | — |
Return on capital | -41.53% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -12.79M | -58.68% |
Cash mula sa mga operasyon | -11.84M | -93.39% |
Cash mula sa pag-invest | 24.00M | 386.62% |
Cash mula sa financing | 0.00 | 100.00% |
Net change in cash | 12.16M | 688.33% |
Malayang cash flow | -7.24M | -119.86% |
Tungkol
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Itinatag
Set 2007
Website
Mga Empleyado
34
